ACE2 and COVID-19: Not only would they contribute to adverse effects, but RAAS inhibitors even in combination with other drugs, would continue to up regulate the ACE2 protein, which would increase the risk of the SARS-CoV-2 virus entering the body According to statistics from April 2020, the ethnic minority population makes up the most cases of COVID-19 in both Europe and the United States.